Middle East & Africa Osteoarthritis Therapy Market Forecast to 2030

At 6.5% CAGR, Middle East & Africa Osteoarthritis Therapy Market is Speculated to be Worth US$ 762.98 Million by 2030, says the Research Team

According to the Research Team’ research, the Middle East & Africa osteoarthritis therapy market was valued at US$ 460.00 million in 2022 and is expected to reach US$ 762.98 million by 2030, registering a CAGR of 6.5% from 2022 to 2030. More effective treatment options and innovative therapy options reducing dependency on medications are among the critical factors attributed to drive the Middle East & Africa osteoarthritis therapy market growth.

Currently, there is no cure for OA. A group of clinical research scientists, through clinical trials, reveal that they are developing innovative treatment target options that can stop the progression of OA. For example, in November 2021, LG Chem company announced the initiation of a clinical trial for next-generation new drugs to treat arthritis.Additionally, in October 2021, Pacira BioSciences, Inc. announced the acquisition of Flexion Therapeutics to treat non-opioid pain management “ZILRETTA”. The drug approved in 2017 is the first and only approved treatment for OA knee pain utilizing extended-release microsphere technology. In September 2023, Sorrento Therapeutics, Inc. announced positive Phase 2 top-line clinical trial results for the “Resiniferatoxin (RTX) program”. The Phase 2 trial is a multi-center, double-blind, placebo, and active-controlled study assessing the efficacy and safety of several dose groups of RTX to manage pain in patients with moderate-to-severe OAK. Also, Sorrento decided to include an active approved competitor drug, “Zilretta,” in the current clinical trial protocol.

On the contrary, the product recall hampers the growth of Middle East & Africa osteoarthritis therapy market.

Based on therapy type, the Middle East & Africa osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held 42.7% market share in 2022, amassing US$ 196.57 million. It is projected to garner US$ 334.10 million by 2030 to register 6.9% CAGR during 2022-2030.

In terms of disease indications, the Middle East & Africa osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held 54.0% share of Middle East & Africa osteoarthritis therapy market in 2022, amassing US$ 248.34 million. It is anticipated to garner US$ 419.63 million by 2030 to expand at 6.8% CAGR during 2022-2030.

Based on end user, the Middle East & Africa osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held 33.5% share of Middle East & Africa osteoarthritis therapy market in 2022, amassing US$ 153.89 million. It is predicted to garner US$ 248.88 million by 2030 to expand at 6.2% CAGR between 2022 and 2030.

Based on country, the Middle East & Africa osteoarthritis therapy market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 36.9% share of Middle East & Africa osteoarthritis therapy market in 2022. It was assessed at US$ 169.93 million in 2022 and is likely to hit US$ 285.02 million by 2030, registering a CAGR of 6.7% during 2022-2030.

Key players operating in the Middle East & Africa osteoarthritis therapy market are Estar Technologies Ltd, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, and Medi GmbH & Co KG, among others.

In March-2022, VQ OrthoCare introduced the OActive Align Osteoarthritis Knee Brace. The OActive Align offers clinicians an easy solution for custom-fitting and aligning the brace to produce exceptional patient outcomes. The brace employs a unique combination of features that precisely fit the anatomy, align the brace hinge axis, and secure it in its most effective position for corrective pain relief.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa osteoarthritis therapy market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa osteoarthritis therapy market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. Middle East & Africa Osteoarthritis Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market – Middle East & Africa Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. Middle East & Africa Osteoarthritis Therapy Market Analysis – by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Osteoarthritis Therapy Market Analysis – by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Osteoarthritis Therapy Market Analysis – by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Osteoarthritis Therapy Market – Country Analysis
10.1 Middle East & Africa Market Overview
10.1.1 Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.4.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.4.5 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Estar Technologies Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DePuy Synthes Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bioventus Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Omron Healthcare Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medi GmbH & Co KG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the the Reporting Teams

LIST OF TABLES

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 4. South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 5. South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 6. Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 7. Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 8. Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 9. United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 10. United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 11. United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 12. Rest of Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 13. Rest of Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 14. Rest of Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies

LIST OF FIGURES

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) – by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) – by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) – by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa: Osteoarthritis Therapy Market – Revenue by Key Countries 2022 (US$ Million)
Figure 26. Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Middle East & Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Osteoarthritis Therapy Market